ASH 2023: MRD Highlights in BioPharma Drug Development

Read More

Chronic Obstructive Pulmonary Disease Alters Immune Cell Composition and Immune Checkpoint Inhibitor Efficacy in Non–Small Cell Lung Cancer

Mark et al.
American Journal of Respiratory and Critical Care Medicine
Papers
February 2018
Authors and Affiliates
Nicholas M. Mark1,2, Julia Kargl2,3, Stephanie E. Busch2, Grace H. Y. Yang2, Heather E. Metz2, Huajia Zhang2, Jesse J. Hubbard2, Sudhakar N. J. Pipavath4, David K. Madtes1,2, and A. McGarry Houghton1,2,5 1Division of Pulmonary and Critical Care, and 4Department of Radiology, University of Washington, Seattle, Washington; 2Clinical Research Division and 5Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; and 3Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria